Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cytosorbents

1.09
+0.02001.87%
Post-market: 1.090.00000.00%16:00 EDT
Volume:69.36K
Turnover:74.19K
Market Cap:68.25M
PE:-3.79
High:1.11
Open:1.04
Low:1.03
Close:1.07
Loading ...

CytoSorbents Corporation Conducted Annual Stockholders Meeting

Reuters
·
3 hours ago

Cytosorbents Announces Expiration of Series B Warrants

TIPRANKS
·
12 Jun

CytoSorbents Reports Q1 2025 Product Sales of $8.7M, Marking 3% Decrease Year-Over-Year, Despite Strong International Performance

Reuters
·
05 Jun

CytoSorbents Corporation to Participate in Jefferies Global Healthcare Conference in New York

Reuters
·
29 May

Cytosorbents Is Maintained at Buy by D. Boral Capital

Dow Jones
·
16 May

Cytosorbents Price Target Maintained With a $1.00/Share by HC Wainwright & Co.

Dow Jones
·
15 May

CytoSorbents Reports Q1 2025 Revenue Drop of 3%, Operating Loss Improves by 17%

Reuters
·
15 May

Cytosorbents Q1 Product Gross Margin 71%

THOMSON REUTERS
·
15 May

Cytosorbents Corp expected to post a loss of 7 cents a share - Earnings Preview

Reuters
·
13 May

Cytosorbents Is Maintained at Buy by D. Boral Capital

Dow Jones
·
02 May

CytoSorbents: FDA issues denial letter for De Novo Request for DrugSorb-ATR

TIPRANKS
·
02 May

CytoSorbents Corporation Pursues Resolution with FDA for DrugSorb-ATR to Address Critical Bleeding Risks in CABG Patients

Reuters
·
02 May

Cytosorbents Provides Regulatory Update for Drugsorb-Atr

THOMSON REUTERS
·
02 May

Cytosorbents Corp: on April 25, FDA Issued a Denial Letter Regarding De Novo Request for Drugsorb-Atr

THOMSON REUTERS
·
02 May

Cytosorbents Corp: FDA Identifying Remaining Deficiencies That Must Be Addressed Before De Novo Request Can Be Granted

THOMSON REUTERS
·
02 May

CytoSorbents Provides Regulatory Update for DrugSorb-ATR

PR Newswire
·
02 May

CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights

PR Newswire
·
29 Apr

CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program

PR Newswire
·
21 Apr

BRIEF-Cytosorbents Appoints Thomas Shannon As Vice President Of Marketing For North America

Reuters
·
14 Apr

Press Release: CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America

Dow Jones
·
14 Apr